Equities researchers at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
View Our Latest Analysis on SNES
SenesTech Stock Up 6.9 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
See Also
- Five stocks we like better than SenesTech
- What Are Dividend Challengers?
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Stock Market Upgrades: What Are They?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Do ETFs Pay Dividends? What You Need to Know
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.